Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yep, once we lay waste to the .04's, this thing will move quickly into the teens hopefully before actual results come out. We're heading higher I have no doubt, just a matter of when.
It will be interesting to see what Mann does now with his buying. Will he have to stop before actual hard data comes out? Because it looks like he bought right up until this preliminary results came out, albeit without any data.
Yeah I agree. I see this thing going to explode, especially once we break into the .05's
MM figuring out a way to quietly cover their positions over the next few weeks.....lol
Should be a fun few weeks here with buying in anticipation of actual results.
I agree. Without news this has not held above 200 dma at all. Fully expect a drop below unless we get some news.
I would love a PR saying they are going to announce pre-clinical trial data in about a week or 2. Would definitely send this skyward in anticipation.
Yeah breaking the 200 ma today might be a challenge. We could need news to do that although I'm hopeful we break above without it. Everyone is waiting on the heart trial results, but we have 2 other trials that are over 4 months and 1 other that has been almost 3 months. Could get a lot of pr's in the 4Q!
A break above the 200 ma would be huge!
When was the last day we had more buys then sells? Every single day it's a lopsided amount of selling vol compared to buying. But she doesn't seem to want to go any lower than .02 which is good. Getting over the 50 day seems to be difficult right now.
I for one am surprised how well it's been holding in the mid 2's. There has been a ton of selling over the last 2 months compared to buying and yet it refuses go lower. Yes frustrating to watch, but with 4 pre-clinical trials, news could hit at any time.
Silly u kids be careful!
Yep, we are definitely at the mercy of news, even if we get a pump right now without news it would probably just drop back down like it did when it ran to over .13. Lots of potential catalysts with 4 pre-clinical trials going on. Of course there is some dilution going on but really it's just the lack of interest from any new buyers. We need a spark!
Yea 50 ma might be tough to crack right now, with the 200 ma not too far off either. Would be extremely bullish if we could and hold above. Still ultimately need news in order to sustain and propel this way higher.
Yeah we will get an er in the next couple weeks or so, but other than that it's hard to tell. Collier said they are in ideal shape to complete the study, so if you go 3 months out from that update, that puts us around late September. Obviously could be sooner just trying to give a educated guess.
No reason other than oversold from the end of June update. Still need a catalyst eventually to propel this much higher.
Yeah I agree it's just when you originally say 1Q and then you update the patent and say 2Q and now it looks like at least a couple more months at a minimum, you lose credibility and it was easy to see this sell off with no catalyst for awhile. No pre-clinical trial should take longer than 6 months max for initial results unless there is something that went wrong with the trial. That would put us around late September at the absolute latest for initial heart results.
Your right it shouldn't but I'm taking worst case scenario. These pre-clinical trials should take 3-6 months max to complete. Heart trial we should here by early September I would think.
After the last update I'm not sure what else you want them to say at this point in time. They said they would update and release pre-clinical trial results as soon as they have them ready. There are 3 other trials that have also started so by the end of the year we should hear something on all of them or most. I don't think people necessarily want to hear from the co, but instead just want the sp to rise to a higher level. Unfortunately they just can't create news for the sake of the sp. Good sign that Mann has continued to buy and they have all deferred their salaries. Tough to be long with these early bios, but with the upcoming catalysts by the end of the year, this could move upwards fast.
Why on earth would an office mean anything??? Do you want to pay more overhead for what? Maybe they should hire a couple secretaries and an office manager to boot.
While I can understand the frustration, what can the company possibly do at this point? All the top officers have deferred their pay, the CEO has been buying on the open market now for over 8 months, and they have launched 4 pre-clinical trials. These trials cost money and so does operating the company. Everyone including those at ENDV want to release positive pre clinical trial data, as it will definitely help raise market cap. People that are complaining don't understand or refuse to understand what they are investing in. A novelty therapy that is in it's infancy with no data as of yet. So unless we get another pump like the last one or some data, this is how things will go.
I'm liking this price action over the last 2 weeks. It was expected that this was going much lower when initial trial results would be delayed past 2Q. But the price is holding up fairly well and we have been trading sideways for quite some time. Should hopefully see a move north soon.
Cmon man your acting like you are buying a blue chip stock. You do realize how speculative and risky these types of stocks are? Why do you think it's on the OTC and sp is at where it's at? Your basically buying a lottery ticket, and you want that ticket to be a sure thing. People think it's easy to get rich I guess.
This is what happens when very few true longs here, and bid support has been incredibly fragile/weak now for months. Enormous pump from .01 to .13, and most, if not all, have sold and gone.
Same device/platform
My 6 month timeframe is not just for the heart study, but for all 4 clinic trials that are taking place. Heart study could be another month or 2, but either way all should be wrapped up by years end, and then we may see an investment deal and so on so on.
Yes I agree with you. People act as if they released negative trial results yesterday when in fact nothing has changed other than some clarity on certain issues, most of which should have been self evident. Bottom line is only results will get sp and mc to move upwards, unless of course we get another pump again beforehand. Anyone complaining of dilution is either misguided or uninformed. They have deferred salaries and Mann has been buying on the open market for over 6 months which are very positive signs long term. Nobody likes to look at their acct and be down 50% or maybe even more. But this is the OTC and this company is really in it's infancy with no pre-trial results to date yet. Waiting game and what entry point can be brutal, as things will be extremely volatile until we get some results. All signs are at least pointed in the right direction, and by the end of the year things should look drastically different one way or another.
Catch 22 here. Obviously nice to hear from the company, but this also signals to the flippers/shorts/day traders, that results are still a little ways off. Which is why the sell off this morning. People looking to get back in at a lower price plain and simple. Anticipation and build-up started with the pump a couple of months ago, probably a bit premature, and when we got closer to the end of 2Q it was fairly obvious we were not getting results. So, in the short run looks like there might be a lot of pain, but things can change quickly and now it will be almost impossible to judge when those pre-clinical trial results will come.
No problem and I realize the other times when IHUB was a little delayed in posting the 4's, but those times we could clearly see the 1 & 2k lots being bought. Either way we are getting close to some sorta update, whether it be today or in the next couple weeks. Plus, by the end of 3Q we should have most if not all the initial data from the other 3 trials. Lot's of upcoming catalysts, should be exciting 2H.
Yep exactly the way I see it. His last buy was on Friday and reported on Monday. Actually we should get 4's today from Tuesday if he did purchase. I've been watching to see those 1k and 2k lot purchases, and don't think there has been any, maybe a few over the last few days.
Mann will have to stop buying before we see pre-clinical trial data in my opinion. So when the form 4's dry up and stop that could be a good indicator news is imminent. Although the trend has been downward, I don't see it going to much further down until we get news. If the news is negative, then sure we'll go lower. Valid excuse so far from Q1 to Q2, but can't imagine that big of a delay if any since these are just pre-clinical trials.
Yep exactly. Definitely a very high risk/reward stock. Initial positive results though would be huge with all the other clinicals supposedly underway. I guess we'll find out sooner or later.
Looks like it's going to be a very volatile day. Large spreads. Almost to the end of 2Q, and any delay would be a big negative. Hope to hear something next week. These are just pre-clinical trials so can't imagine why their would be a delay.
Ok thanks that definitely helps.
Does anyone know if they started/ran the original heart trial from Dec? Or did they work on getting the new tech/patent that was launched in late March. Would be interesting to know how that trial was going with the original patent if that was the case.
When I talked to Steve in IR last year, they weren't to concerned with mc because their feeling was that it would take care of itself once these pre-clinical trial results kicked in. And yes they are dealing with vulture financing co because that is all they can get at this pt. Long story short they launched 4 pre-clinical trials, realizing in the short-term sp will be affected, but over the next 3-6 months they are banking on good results to cash in and then everything will flow from there. This first result will be HUGE going forward, and will increase mc tremendously if the results are favorable.
People are getting tired and frustrated, but there is very little bid support because of the lack of vol buys. And noteholders don't care about sp as they make money no matter what the sp is. Just like last year when it went from .87 down to .01. They continued to relentlessly convert. I believe most retail are already locked in to their positions for the most part. News will change everything either way when it comes.
I think the starting over of the trial in late March put the pre-trial results in late June. And I also agree we'll get something by the eom, hopefully the results, or the reason for the delay. They never said for sure results would come by 2Q, only that they anticipated they would. Which means it could run into July possibly, worse case scenario. There has been some selling, which could be dilution, but for the most part retail has not been buying, as either they established their position awhile ago during the big run-up, or they have sold off on the way back down.
Impossible to uplift at this pt, as they were originally planning to finish heart trial during 1Q. Newly filed patent is supposed to superior to the old one, so had to redo trial probably. It can definitely be frustrating or nerve wracking waiting as we come to the end of the 2Q, but until then there is not much we can do. I would think either way we'll get updated with results or the reason for the delay within the next couple of weeks.
Binary event within a few weeks will make everything happening until then meaningless. Vol has dried up, not much selling and pretty good support in the .05's. All you can do is sit back and wait until results come out.